These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6336961)

  • 21. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Meloni G; Korbling M; Carella A; Herve P; Burnett A; Rizzoli V; Alessandrino EP; Bjorkstrand B
    Leukemia; 1991 Oct; 5(10):896-904. PubMed ID: 1835746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous bone marrow transplant in acute myeloid leukemia in first remission.
    Cassileth PA; Andersen J; Lazarus HM; Colvin OM; Bennett JM; Stadtmauer EA; Kaizer H; Weiner RS; Edelstein M; Oken MM
    J Clin Oncol; 1993 Feb; 11(2):314-9. PubMed ID: 8426209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
    Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T
    Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous marrow transplantation in first remission acute myeloid leukemia using marrow purged with mafosfamide.
    Rizzoli V; Mangoni L; Carlo-Stella C; Carella AM; Coser P; Angrilli F; Porcellini A; Bernabei PA
    Bone Marrow Transplant; 1991; 7 Suppl 2():37. PubMed ID: 1878710
    [No Abstract]   [Full Text] [Related]  

  • 27. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
    Hagenbeek A; Martens AC
    Leukemia; 1989 Jul; 3(7):535-7. PubMed ID: 2659904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autologous bone marrow transfusion in the treatment of adults with hematologic neoplasms. Experiences from Bern].
    Brun del Re GP; Tschopp L; Cerny T; Bucher U
    Schweiz Med Wochenschr; 1989 Jun; 119(25):902-10. PubMed ID: 2667130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
    O'Briant KC; Shpall EJ; Houston LL; Peters WP; Bast RC
    Cancer; 1991 Sep; 68(6):1272-8. PubMed ID: 1873781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
    Tomás JF; Gómez-García de Soria V; Pinilla I; Lamana M; Figuera A; Arranz R; Cámara R; Fernández-Villalta MJ; Alegre A; Fernández-Rañada JM
    Med Clin (Barc); 1997 Feb; 108(6):201-6. PubMed ID: 9102484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autograft of bone marrow treated by in vitro chemotherapy (Asta Z 7557) for consolidation of acute leukemia in adults in the first complete remission].
    Laporte JP; Gorin NC; Douay L; Lopez M; Najman A; Stachowiak J; Aegerter P; Lemonnier MP; Pene F; Kantor G
    Presse Med; 1987 Feb; 16(7):338-42. PubMed ID: 2950482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplantation of non-purified autologous bone marrow in patients with AML in first remission.
    Löwenberg B; Abels J; van Bekkum DW; Dzoljic G; Hagenbeek A; Hendriks WD; van de Poel J; Sizoo W; Sintnicolaas K; Wagemaker G
    Cancer; 1984 Dec; 54(12):2840-3. PubMed ID: 6388819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
    Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
    Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconstitution of haemopoietic system with autologous marrow taken during relapse of acute myeloblastic leukaemia and grown in long-term culture.
    Chang J; Coutinho L; Morgenstern G; Scarffe JH; Deakin D; Harrison C; Testa NG; Dexter TM
    Lancet; 1986 Feb; 1(8476):294-5. PubMed ID: 2868165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
    Ozsahin M; Belkacémi Y; Pène F; Laporte J; Rio B; Leblond V; Korbas D; Touboul E; Gorin NC; Schlienger M; Laugier A
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):71-7. PubMed ID: 12118567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graft.
    Körbling M; Hess AD; Tutschka PJ; Kaizer H; Colvin MO; Santos GW
    Br J Haematol; 1982 Sep; 52(1):89-96. PubMed ID: 6214268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical results.
    Hervé P; Cahn JY; Plouvier E; Flesch M; Tamayo E; Leconte des Floris R; Peters A
    Invest New Drugs; 1984; 2(2):245-52. PubMed ID: 6381384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological-mediated purging with mafosfamide in acute and chronic myeloid leukemias. The Italian Study Group.
    Rizzoli V; Mangoni L
    Prog Clin Biol Res; 1990; 333():21-36; discussion 37-8. PubMed ID: 2308982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
    Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Hess AD; Santos GW
    Leuk Lymphoma; 1993 Oct; 11(3-4):215-20. PubMed ID: 8260896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.
    Shpall EJ; Jones RB; Bast RC; Rosner GL; Vandermark R; Ross M; Affronti ML; Johnston C; Eggleston S; Tepperburg M
    J Clin Oncol; 1991 Jan; 9(1):85-93. PubMed ID: 1985173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.